Sign in to view content

Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)

Dante Joseph Pieramici, MD

Video
Published 2020

Related

Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Updates from the Field
2019
Early Treatment Patterns and Outcomes in Patients With Diabetic Macular Edema Treated With Faricimab: FARETINA-DME Study
Durga Borkar, MD
Annual Meeting Talks
2023
Vision Threatening Complications in Patients With Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials
Diana V Do, MD, FASRS
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

See more